Summer Special! Get NewsNow Essentials at just £3.49 a month (12% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £3.49 a month (12% OFF!). Subscribe and saveSummer Special! Upgrade here at £3.49/m (12% OFF!)

Home
Hot Topics
Nigeria
Politics
Crime
Premier League
Economy
Africa
World
Entertainment
Sport
La Liga
Serie A
Bundesliga
Lifestyle
Bitcoin
Cryptocurrencies
Sensational News

European Medicines Agency
EU
EU/Ukraine
Eurozone
GDPR
EU/China
European Commission
European Central Bank
European Parliament
MEPs
European Environment Agency
Schengen
EU/Russia
Topics

Advertisement

European Medicines Agency

Share

Top Latest Popular

EMA selects TrialAssure anonymisation platform for clinical trial documents Pharmafile 6d

Pharmafile 6d

TrialAssure Clinical trial

Celltrion targets European secukinumab market with EMA filing for CT-P55 JD Supra 2d

JD Supra 2d

CT-P55 COSENTYX

Atsena gains EMA orphan status for two gene therapies PharmaTimes 7d

PharmaTimes 7d

Advertisement

Advertisement

EU pharma regulators publish annual AI observatory report Osborne Clarke 5d

Osborne Clarke 5d

Biotechnology AI

EMA recommends granting marketing authorisation approval for Nezglyal PMLiVE 12:53 Mon, 27 Jul

PMLiVE 12:53 Mon, 27 Jul

EMA issues positive Opinion for orphan drug Designation of Imsidolimab for GPP Rare Disease Advisor 18:18 Mon, 27 Jul

Rare Disease Advisor 18:18 Mon, 27 Jul

Imsidolimab Global Health

Advertisement

Advertisement

Latest

Monday

Celltrion Targets European Secukinumab Market with EMA Filing for CT-P55 JD Supra 19:38 Mon, 03 Aug

U.S. FDA Grants Orphan Drug Designation to Zai Lab’s DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs) Business Wire (Press Release) 12:07 Mon, 03 Aug

Friday

EU pharma regulators publish annual AI observatory report Osborne Clarke 13:44 Fri, 31 Jul

Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate Business Wire (Press Release) 12:03 Fri, 31 Jul

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate Business Wire (Press Release) 07:32 Fri, 31 Jul

Thursday

EMA selects TrialAssure anonymisation platform for clinical trial documents Pharmafile 13:54 Thu, 30 Jul

In the last month

Zvra Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Zevra Therapeutics (Zvra) Business Wire (Press Release) 15:11 Wed, 29 Jul

Atsena gains EMA orphan status for two gene therapies PharmaTimes 12:04 Wed, 29 Jul

TrialAssure selected as EMA’s official clinical trial anonymisation partner Clinical Trials Arena 11:16 Wed, 29 Jul

Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer Business Wire (Press Release) 12:49 Tue, 28 Jul

Advertisement

Advertisement

Advertisement

About our EMA news

Latest news on the European Medicines Agency, also known as the EMA, a European Union agency responsible for the evaluation and supervision of pharmaceuticals.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Europe Europe
- Back to Europe European Union
  - Ursula von der Leyen
  - Josep Borrell
  - Digital Services Act
  - ECB ECB
  - Erasmus Erasmus
  - EU Summit EU Summit
  - Europol Europol
  - Eurozone Eurozone
  - MEPs MEPs
  - European Commission
  - European Court of Justice
  - European Environment Agency
  - European Investment Bank
  - European Medicines Agency
  - European Parliament
  - Frontex Frontex
  - ETIAS ETIAS
  - GDPR GDPR
  - Global Gateway
  - Schengen Schengen
  - EU/Belarus EU/Belarus
  - EU/China EU/China
  - EU/Hungary EU/Hungary
  - EU/India EU/India
  - EU/Qatar EU/Qatar
  - EU/Russia EU/Russia
  - EU/Ukraine EU/Ukraine